BDBM350526 N-(4-bromophenyl)-2-(4,4-diethyl- 2,5-dioxoimidazolidin-1-yl)acetamide::US10208071, Table 3.2::US10434112, Table 3.2::US10799518, Structure TABLE 3.2

SMILES CCC1(CC)NC(=O)N(CC(=O)Nc2ccc(Br)cc2)C1=O

InChI Key InChIKey=SIZAXIVFKSSJKA-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350526   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350526(N-(4-bromophenyl)-2-(4,4-diethyl- 2,5-dioxoimidazo...)
Affinity DataEC50:  9.60E+4nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350526(N-(4-bromophenyl)-2-(4,4-diethyl- 2,5-dioxoimidazo...)
Affinity DataEC50:  96nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350526(N-(4-bromophenyl)-2-(4,4-diethyl- 2,5-dioxoimidazo...)
Affinity DataEC50:  96nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent